Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
80%-100%, Zurich, fixed-term ETH Zurich is one of the world’s leading universities specialising in science and technology. It is renowned for its excellent education, its cutting-edge fundamental
-
dedicated to advancing antibiotic research through close collaboration among biologists, clinicians, and engineers. Its overarching goal is to rejuvenate antibiotic discovery by developing laboratory models
-
100%, Zurich, fixed-term The Group for Sustainability and Technology (SusTec) within the Department of Management, Technology, and Economics of ETH Zurich investigates the role of policy
-
The Cardiopulmonary Physiology And Mechanical Support (CPAMS) Research Group offers this position at the Department of Biomedical Engineering (DBE) at the University of Basel. The DBE is jointly run
-
interdisciplinary scientists and engineers to develop and apply open-source software in a diverse range of research topics. Profile We are looking for an experienced bioinformatics software engineer to engage in
-
Materials science and technology are our passion. With our cutting-edge research, Empa's around 1,100 employees make essential contributions to the well-being of society for a future worth living
-
Materials science and technology are our passion. With our cutting-edge research, Empa's around 1,100 employees make essential contributions to the well-being of society for a future worth living
-
Materials science and technology are our passion. With our cutting-edge research, Empa's around 1,100 employees make essential contributions to the well-being of society for a future worth living
-
Materials science and technology are our passion. With our cutting-edge research, Empa's around 1,100 employees make essential contributions to the well-being of society for a future worth living
-
, control engineering, and immunoengineering. This position is part of our newly funded ERC Advanced Grant, which aims to develop genetically engineered feedback control circuits in human T cells to tackle